Premarket Mover: Syros Pharmaceuticals Inc (SYRS) Up 22.73%

Syros Pharmaceuticals Inc (SYRS) has gained Thursday morning, with the stock climbing 22.73% in pre-market trading to 1.08. SYRS's short-term technical score of 30 indicates that the stock has traded less bullishly over the last month than 70% of stocks on the market. In the Biotechnology industry, which ranks 88 out of 146 industries, Syros Pharmaceuticals Inc ranks higher than 29% of stocks. Syros Pharmaceuticals Inc has fallen 3.30% over the past month, closing at $0.86 on July 7. During this period of time, the stock fell as low as $0.79 and as high as $1.03. SYRS has an average analyst recommendation of Strong Buy. The company has an average price target of $10.80.

SYRS has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on SYRS!

See Full SYRS Report

Syros Pharmaceuticals Inc has a Long-Term Technical rank of 9. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 91% of the market scoring higher. In the Biotechnology industry which is number 101 by this metric, SYRS ranks better than 101% of stocks.

Important Dates for Investors in SYRS:

-Syros Pharmaceuticals Inc is set to release earnings on 8/9/2022. Over the last 12 months, the company has reported EPS of $-1.54. -We do not have a set dividend date for Syros Pharmaceuticals Inc at this time. Click Here To Get The Full Report on Syros Pharmaceuticals Inc (SYRS)